Literature DB >> 21429588

Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation.

Adriana Weinberg1, Laura Enomoto, Roland Marcus, Jennifer Canniff.   

Abstract

Ovarian steroid hormones reduce cell-mediated immunity (CMI), perhaps by increasing regulatory T cells. We examined the relationship of estrogen and progesterone plasma concentrations during the menstrual cycle with circulating regulatory T cells (Treg cells) and with varicella-zoster virus (VZV)-specific lymphocyte proliferation (VZV-LPA). Twenty healthy and 20 HIV-infected women were tested at 1-4, 10-14, and 20-24days of the menstrual cycle. HIV-infected women experienced significant increases in the frequency of peripheral blood CD4+IL10+ and CD8+FoxP3+ Treg cells from the early and late follicular phases to the luteal phase of their cycles. Healthy women experienced significant increases only in CD4+IL10+ Treg cells. The increase in CD4+IL10+ Treg cells between the late follicular and the luteal phases of HIV-infected and uninfected women significantly correlated with the corresponding increases in progesterone plasma concentrations. VZV-LPA results decreased from the early and late follicular phases to the luteal phase in both groups. The decrease in VZV-LPA results significantly correlated with the increase in CD4+IL10+ Treg cells underscoring the potential immunosuppressive effect of the progesterone-stimulated Treg cells. In conclusion, the increase in progesterone levels during the menstrual cycle was associated with higher Treg frequencies and lower CMI.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429588     DOI: 10.1016/j.jri.2010.11.009

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  14 in total

1.  Possible influence of menstrual cycle on lymphocyte X chromosome mosaicism.

Authors:  K Gersak; M Perme-Pohar; A Veble; B M Gersak
Journal:  J Assist Reprod Genet       Date:  2014-11-16       Impact factor: 3.412

2.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

Review 3.  Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Authors:  Rowena E Johnston; Mary M Heitzeg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

4.  Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristics.

Authors:  Adriana Weinberg; Amanda A Allshouse; Samantha Mawhinney; Jennifer Canniff; Lorie Benning; Eryka L Wentz; Howard Minkoff; Mary Young; Marek Nowicki; Ruth Greenblatt; Mardge H Cohen; Elizabeth T Golub
Journal:  J Acquir Immune Defic Syndr       Date:  2012-05-01       Impact factor: 3.731

5.  Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.

Authors:  Adriana Weinberg; Jeong-Gun Park; Ronald Bosch; Alice Cho; Elizabeth Livingston; Fran Aweeka; Yoninah Cramer; D Heather Watts; Amneris E Luque; Susan E Cohn
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

Review 6.  Gonadal function and reproductive health in women with human immunodeficiency virus infection.

Authors:  Swaytha Yalamanchi; Adrian Dobs; Ruth M Greenblatt
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

7.  HIV-1 Tat promotes age-related cognitive, anxiety-like, and antinociceptive impairments in female mice that are moderated by aging and endocrine status.

Authors:  Alaa N Qrareya; Fakhri Mahdi; Marc J Kaufman; Nicole M Ashpole; Jason J Paris
Journal:  Geroscience       Date:  2020-09-17       Impact factor: 7.713

8.  The Association Between HIV Status, Estradiol, and Sex Hormone Binding Globulin Among Premenopausal Women in the Women's Interagency HIV Study.

Authors:  Sally B Coburn; Jodie Dionne-Odom; Maria L Alcaide; Caitlin A Moran; Lisa Rahangdale; Elizabeth T Golub; Leslie Stewart Massad; Dominika Seidman; Katherine G Michel; Howard Minkoff; Kerry Murphy; Todd T Brown; Kala Visvanathan; Bryan Lau; Keri N Althoff
Journal:  J Womens Health (Larchmt)       Date:  2022-01-17       Impact factor: 2.681

9.  Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.

Authors:  Andrew Vallely; Lisa Fitzgerald; Voletta Fiya; Herick Aeno; Angela Kelly; Joyce Sauk; Martha Kupul; James Neo; John Millan; Peter Siba; John M Kaldor
Journal:  BMC Res Notes       Date:  2012-11-01

Review 10.  The Endocrine Milieu and CD4 T-Lymphocyte Polarization during Pregnancy.

Authors:  Barbara Polese; Virginie Gridelet; Eleni Araklioti; Henri Martens; Sophie Perrier d'Hauterive; Vincent Geenen
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.